Rezvoglar KwikPen

INSULIN GLARGINE-AGLR · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Rezvoglar KwikPen, covering 2021-12-17 to 2024-08-09. Get the full timeline:

Most recent: FDA Approved: REZVOGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)